International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
By Lauren B. Krupp, M. Tardieu, M. Amato, B. Banwell, T. Chitnis, R. Dale, A. Ghezzi, R. Hintzen, A. Kornberg, D. Pohl and 3 more. Multiple Sclerosis, 2013
1,042 citations recorded by the source corpus.
Subfields: Immunology, Neurology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/e2f38a1515b35ed7d6fc317295acab081650a81c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- P. Waters
- A. Roca-Fernández
- A. Vincent
- S. Messina
- M. Juryńczyk
- R. Everett
- M. Woodhall
- G. Tackley
Citations in the corpus
- Clinical presentation and prognosis in MOG-antibody disease: a UK study (2017, background): “…2007 (Wingerchuk et al., 2007) criteria but only 17 fulfilled the NMOSD 2015 (Wingerchuk et al., 2015) criteria (because of the requirement for more than one area to be involved if AQP4 antibody-negative), two of whom fulfilled the ADEM criteria defined primarily for children (Krupp et al., 2013).”